tadalafil dosage - viagra - augmentin uses - http://sildenafilgeneric-citrate.com/ - levitra 20mg vs viagra 100mg - furosemide for dogs - lisinopril hctz - cialis generic - gabapentin 300mg - doxycycline hyclate 100mg

Posts Tagged 'Cell-in-a-Box'

Nuvilex, Inc. Pancreatic Cancer Trials Could Make “Cell-in-a-Box” Gold Standard

Nuvilex, Inc. Pancreatic Cancer Trials Could Make “Cell-in-a-Box” Gold Standard

Written by ι Stock Market Media Group Staff — April 29. 2013

While many biotech and pharmaceutical companies are designing one drug after another to address specific problems, Nuvilex, Inc. (OTCQB: NVLX) is using its own living cell encapsulation as a “one size fits all” type solution.  The company is off to a great start at getting its “Cell-in-a-Box” technology on the map with its work in late stage, inoperable pancreatic cancer. 

Nuvilex is headquartered in Silver Spring, Maryland, and while it is a ...

Read More →
0

Potential Future Sales of Nuvilex, Inc. Cancer Treatments Make Investment in Cell-in-a-Box Worth It

Potential Future Sales of Nuvilex, Inc. Cancer Treatments Make Investment in Cell-in-a-Box Worth It

Written by ι Stock Market Media Staff — March 26, 2013

Nuvilex, Inc. (OTCQB: NVLX) is a small biotechnology company out of Silver Spring, Maryland, but its future might be anything but small.  As the company diligently prepares for its Phase III pancreatic cancer trials, the almost $30-million the company has invested in its unique and proprietary living cell encapsulation or “Cell-in-a-Box” technology could be money well spent given the return in annual sales that cancer drugs bring ...

Read More →
0

Nuvilex, Inc. Price Valuation Justifies Investor Confidence in Biotech

Nuvilex, Inc. Price Valuation Justifies Investor Confidence in Biotech

Written by ι Stock Market Media Group Staff — April 25, 2013

Nuvilex, Inc. (OTCQB: NVLX) is an international biotechnology firm quietly going about its business in Silver Spring, Maryland.  The company is currently priced below $0.10/share, and according to a recent valuation report, at this price, it is highly undervalued given the work going on at Nuvilex.

Goldman Small Cap Research released a valuation of Nuvilex based upon its work with pancreatic cancer and its future potential in the medical marijuana arena.  This ...

Read More →
0

Timing is Right for Big Pharma to Add Nuvilex, Inc. Technology to its Pipeline

Timing is Right for Big Pharma to Add Nuvilex, Inc. Technology to its Pipeline

Written by ι Stock Market Media Staff — March 21, 2013

Nuvilex, Inc. (OTCQB: NVLX) has close to $30-million invested in its “Cell-in-a-Box” technology, and as the company gets closer to the start of its Phase III pancreatic cancer trial, the trial may be coming at just the right time!

Over the past month, we have laid out a series of articles that outline how the living cell encapsulation or “Cell-in-a-Box” technology at Nuvilex can dramatically change the ...

Read More →
0

Nuvilex, Inc. and Diabetes Research Institute Have Similar Approach to Islet Cell Transplantation

Nuvilex, Inc. and Diabetes Research Institute Have Similar Approach to Islet Cell Transplantation

Written by ι Stock Market Media Group Staff — April 18, 2013

Nuvilex, Inc. (OTCQB: NVLX) has “Cell-in-a-Box,” the Diabetes Research Institute has BioHub.  One is cell encapsulation technology, and the other is an integrated spongy wafer.  While they have different names and a different structure, the idea is the same – building a fully protected home to house pancreatic islet (insulin-producing) cells for transplantation into diabetics.

Both Nuvilex and the Diabetes Research Institute (DRI) have identified the problem and clearly have a game ...

Read More →
0

Nuvilex, Inc. Cell-in-a-Box Technology Could Revitalize the Stem Cell Phenomenon

Nuvilex, Inc. Cell-in-a-Box Technology Could Revitalize the Stem Cell Phenomenon

Written by ι Stock Market Media Staff — March 12, 2013

Remember not so long ago when every science related conversation seemed to weave its way into a conversation about stem cells?  Back around 2007, there was a real phenomenon going on among biotechnology companies that had anything at all to do with stem cells, and now six years later with more research in the books, that enthusiasm has waned a bit.

Still, stem cell treatments are being developed for many ailments including ...

Read More →
0
Page 8 of 9 «...56789
ContactUs.com